We’ve recently updated our valuation analysis.

LivePerson Valuation

Is LPSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LPSN?

Other financial metrics that can be useful for relative valuation.

LPSN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.5x
Enterprise Value/EBITDA-8.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does LPSN's PS Ratio compare to its peers?

The above table shows the PS ratio for LPSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average7.8x
AVPT AvePoint
3.8x16.6%US$838.2m
RSKD Riskified
3.7x18.9%US$929.3m
SUMO Sumo Logic
5x14.7%US$1.4b
PERF Perfect
18.7x24.7%US$885.8m
LPSN LivePerson
1.8x6.8%US$920.5m

Price-To-Sales vs Peers: LPSN is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (7.8x).


Price to Earnings Ratio vs Industry

How does LPSN's PE Ratio compare vs other companies in the US Software Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.4%
n/an/an/a

Price-To-Sales vs Industry: LPSN is good value based on its Price-To-Sales Ratio (1.8x) compared to the US Software industry average (4.4x)


Price to Sales Ratio vs Fair Ratio

What is LPSN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LPSN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.8x
Fair PS Ratio2.2x

Price-To-Sales vs Fair Ratio: LPSN is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).


Share Price vs Fair Value

What is the Fair Price of LPSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LPSN ($12.22) is trading above our estimate of fair value ($3.89)

Significantly Below Fair Value: LPSN is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LPSN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$12.22
US$13.20
+8.0%
33.0%US$25.00US$8.00n/a10
Jan ’24US$10.14
US$13.45
+32.6%
31.9%US$25.00US$8.00n/a10
Dec ’23US$12.98
US$13.45
+3.6%
31.9%US$25.00US$8.00n/a10
Nov ’23US$10.60
US$14.70
+38.7%
28.4%US$25.00US$8.00n/a10
Oct ’23US$9.42
US$15.78
+67.5%
26.0%US$25.00US$8.00n/a9
Sep ’23US$10.51
US$16.75
+59.4%
19.3%US$25.00US$14.00n/a8
Aug ’23US$13.65
US$20.00
+46.5%
19.4%US$27.00US$15.00n/a8
Jul ’23US$14.41
US$20.38
+41.4%
17.2%US$27.00US$16.00n/a8
Jun ’23US$16.60
US$20.38
+22.7%
17.2%US$27.00US$16.00n/a8
May ’23US$22.62
US$24.20
+7.0%
27.9%US$42.00US$18.00n/a10
Apr ’23US$24.87
US$23.70
-4.7%
27.3%US$42.00US$18.00n/a10
Mar ’23US$23.52
US$24.70
+5.0%
29.6%US$42.00US$18.00n/a10
Feb ’23US$28.43
US$60.69
+113.5%
28.2%US$85.00US$30.00n/a13
Jan ’23US$35.72
US$64.31
+80.0%
18.2%US$85.00US$40.00US$10.1413
Dec ’22US$35.67
US$68.31
+91.5%
15.2%US$85.00US$50.00US$12.9813
Nov ’22US$52.35
US$70.31
+34.3%
13.3%US$85.00US$50.00US$10.6013
Oct ’22US$60.92
US$72.86
+19.6%
10.1%US$85.00US$58.00US$9.4214
Sep ’22US$64.72
US$72.57
+12.1%
9.9%US$85.00US$58.00US$10.5114
Aug ’22US$63.69
US$76.33
+19.9%
7.0%US$85.00US$60.00US$13.6515
Jul ’22US$61.58
US$76.00
+23.4%
7.0%US$85.00US$60.00US$14.4116
Jun ’22US$55.16
US$76.33
+38.4%
7.0%US$85.00US$60.00US$16.6015
May ’22US$54.65
US$77.67
+42.1%
7.0%US$90.00US$65.00US$22.6215
Apr ’22US$55.19
US$77.50
+40.4%
6.9%US$90.00US$65.00US$24.8716
Mar ’22US$67.96
US$77.60
+14.2%
7.1%US$90.00US$65.00US$23.5215
Feb ’22US$64.65
US$72.27
+11.8%
5.8%US$78.00US$65.00US$28.4315
Jan ’22US$62.23
US$69.87
+12.3%
7.9%US$75.00US$55.00US$35.7215

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies